Preliminary safety, pharmacokinetics, and antitumor activity of RMC-9805, an oral, RAS(ON) G12D-selective, tri-complex inhibitor in patients with KRAS G12D pancreatic ductal adenocarcinoma (PDAC) from a phase 1 study in advanced solid tumors Meeting Abstract
| Authors: | Hong, D. S.; Papadopoulos, K.; Kim, D. W.; Parikh, A.; Barve, M.; Powderly, J.; Starodub, A.; Strickler, J.; Li, B. T.; Oberstein, P.; Yu, W.; Bitman, B.; Lally, S.; Lin, W.; Sohoni, S.; Spira, A. |
| Abstract Title: | Preliminary safety, pharmacokinetics, and antitumor activity of RMC-9805, an oral, RAS(ON) G12D-selective, tri-complex inhibitor in patients with KRAS G12D pancreatic ductal adenocarcinoma (PDAC) from a phase 1 study in advanced solid tumors |
| Meeting Title: | 36th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics |
| Journal Title: | European Journal of Cancer |
| Volume: | 211 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2024 Oct 23-25 |
| Meeting Location: | Barcelona, Spain |
| ISSN: | 0959-8049 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2024-10-01 |
| Start Page: | S177 |
| End Page: | S178 |
| Language: | English |
| ACCESSION: | WOS:001345547300452 |
| DOI: | 10.1016/j.ejca.2024.114980 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 502LBA LBA Orals -- Article number: 114980-- Source: Wos |
